Clinical Research Trials


" A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects with Heart Failure with Reduced Ejection Fraction and Decreased Exercise Tolerance "

"The purpose of the study is to find out more about the effects of an investigational drug called omecamtiv mecarbil (OM), when given to people who have heart failure."

Inclusion/Exclusion/Notes: " "

Principal Investigator: Dalton Miranda

Contact: Study Coordinator

Phone (Main): 231-487-3539

IRB Number: 2018-00067

Current Trial Type: 3759392

Status: Open to Enrollment